Nisa Investment Advisors LLC Cuts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nisa Investment Advisors LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 111,739 shares of the medical equipment provider's stock after selling 3,486 shares during the quarter. Nisa Investment Advisors LLC's holdings in Intuitive Surgical were worth $55,341,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of ISRG. Norges Bank bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $2,401,493,000. GAMMA Investing LLC grew its holdings in shares of Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares during the last quarter. Capital Research Global Investors boosted its position in Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after buying an additional 687,906 shares during the period. Northern Trust Corp boosted its position in Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after buying an additional 494,496 shares during the period. Finally, Vanguard Group Inc. boosted its position in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after buying an additional 360,591 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Down 2.7%

ISRG stock traded down $13.99 during midday trading on Friday, reaching $512.06. 2,951,229 shares of the company's stock traded hands, compared to its average volume of 1,679,961. The company has a market cap of $183.53 billion, a price-to-earnings ratio of 75.08, a P/E/G ratio of 5.58 and a beta of 1.64. The firm's fifty day moving average price is $537.85 and its 200-day moving average price is $536.69. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter in the previous year, the business posted $1.50 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently commented on ISRG. Barclays cut their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Royal Bank Of Canada cut their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and cut their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Piper Sandler cut their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Finally, Robert W. Baird dropped their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $592.59.

Insider Activity

In other news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president owned 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.